Frequently Asked Questions

Tirezapitide is a telehealth platform that connects patients with licensed healthcare providers who evaluate whether tirzepatide treatment may be appropriate. We facilitate secure consultations, provider matching, and medication fulfillment through licensed US compounding pharmacies. Tirezapitide does not directly provide medical services, prescribe medications, or dispense pharmaceuticals.

After completing a comprehensive health intake form, you are matched with a licensed provider who reviews your medical history, weight profile, and health goals. Your provider conducts an asynchronous or synchronous evaluation to determine whether tirzepatide may be appropriate for your situation. If a prescription is issued, it is sent to a licensed compounding pharmacy that ships your medication directly to your door.

Eligibility is determined by a licensed healthcare provider based on your medical history, BMI, current health status, and treatment goals. Generally, tirzepatide may be considered for adults 18 and older with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition. Not everyone who applies will qualify. Visit our eligibility page for detailed criteria.

Most patients can complete their health intake form in under 15 minutes. A licensed provider typically reviews your submission within 24 to 48 hours. If tirzepatide treatment is prescribed, medications are usually shipped within a few business days of provider approval.

Telehealth is a well-established model of healthcare delivery used by hospitals, clinics, and health systems nationwide. All Tirezapitide providers are licensed in the states where they practice and follow the same clinical standards as in-person care. Your provider may recommend in-person evaluation or lab work when appropriate to ensure safe prescribing of tirzepatide.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — meaning it activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action may help regulate appetite, slow gastric emptying, and improve insulin sensitivity. It is administered as a once-weekly subcutaneous injection. Tirzepatide was originally developed for type 2 diabetes management and has also been studied for chronic weight management.

While both medications are injectable treatments used for weight management, they work through different mechanisms. Semaglutide is a GLP-1 receptor agonist that targets a single receptor pathway. Tirzepatide is a dual GIP/GLP-1 receptor agonist that targets two receptor pathways simultaneously. This dual-action approach may produce different effects on appetite, blood sugar regulation, and weight loss, though individual responses vary. Your provider can discuss which medication may be more appropriate for your health profile.

Compounded tirzepatide contains the same active ingredient as branded products (Mounjaro, Zepbound) but is prepared by licensed compounding pharmacies rather than the original manufacturer. Compounded medications are not FDA-approved and may differ in formulation, inactive ingredients, concentration, or delivery method. Compounding pharmacies are licensed and regulated by their respective state boards of pharmacy.

The most common side effects of tirzepatide include nausea, diarrhea, decreased appetite, vomiting, constipation, abdominal pain, and indigestion. These gastrointestinal effects are typically most noticeable when starting treatment or increasing the dose, and often diminish over time. More serious but less common risks include pancreatitis, gallbladder problems, and thyroid C-cell tumors. Your provider will review all potential side effects and contraindications before prescribing.

Compounded tirzepatide should be refrigerated between 36-46 degrees Fahrenheit (2-8 degrees Celsius) and protected from light. Do not freeze. Specific storage instructions will be included with your shipment based on the exact formulation from your pharmacy. Never use medication that appears discolored, contains particles, or is past its expiration date.

Getting started is simple: complete our online health intake form, which takes about 10-15 minutes. A licensed provider will review your information and evaluate whether tirzepatide treatment is appropriate for your health profile. If treatment is prescribed, your compounded tirzepatide will be shipped directly to you from a licensed pharmacy.

Most health intake submissions are reviewed within 24 to 48 hours. Because tirzepatide requires careful evaluation of your metabolic health, weight history, and potential contraindications, your provider may request additional information or lab work before making a treatment decision, which may extend the timeline.

Once your tirzepatide prescription is approved and prepared by the pharmacy, medications are typically shipped within 2 to 5 business days. Compounded tirzepatide is shipped with temperature-controlled packaging to maintain medication integrity. Shipping times may vary based on your location.

Yes. Once your medication ships, you will receive a tracking number via email so you can monitor your delivery status. Because tirzepatide requires refrigeration, we recommend being available to receive and refrigerate your package promptly upon delivery.

Your provider will determine the appropriate refill schedule based on your tirzepatide treatment plan and dosing level. Before each refill, you may be asked to complete a brief check-in to update your provider on your progress, side effects, and any health changes. Refills are coordinated based on your schedule unless you or your provider request changes.

Treatment costs vary depending on your tirzepatide dosage, treatment duration, and plan type. Pricing is transparent and will be provided to you before you commit to any treatment. There are no hidden fees. Compounded tirzepatide is generally more affordable than branded alternatives (Mounjaro, Zepbound). Contact us for current pricing information.

Most insurance plans do not cover compounded medications or telehealth consultations through platforms like Tirezapitide. We operate on a self-pay model to keep costs transparent and accessible. Some patients may be able to use HSA or FSA funds for treatment — check with your plan administrator for eligibility.

You may cancel your tirzepatide treatment plan at any time by contacting our support team. Refund eligibility depends on the status of your order. Medications that have already been compounded and shipped generally cannot be returned due to safety regulations. Consultation fees may be non-refundable once a provider review has been completed. Full policy details are available in our Terms of Service.

Yes. Tirezapitide is fully committed to protecting your personal health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA). All data — including your health intake form, provider communications, and prescription details — is encrypted in transit and at rest. Access is restricted to authorized personnel involved in your care. For details, please review our Privacy Policy.

All providers on the Tirezapitide platform are licensed healthcare professionals (physicians, nurse practitioners, or physician assistants) who are credentialed and authorized to practice in the states where they provide care. They are experienced in evaluating patients for GLP-1 and dual GIP/GLP-1 receptor agonist treatments. Provider licensing is verified and maintained on an ongoing basis.

Our partner compounding pharmacies are licensed and regulated by their respective state boards of pharmacy. They operate in compliance with applicable USP compounding standards (including USP 795 and USP 797 for sterile preparations) and are subject to regular inspections. All tirzepatide is prepared in controlled environments with rigorous quality assurance and potency testing protocols.

Tirezapitide is not an emergency medical service. If you are experiencing a medical emergency — including severe abdominal pain, signs of pancreatitis, severe allergic reaction, or difficulty breathing — call 911 or go to your nearest emergency room immediately. Stop using tirzepatide and seek immediate medical attention for any serious adverse reaction. Notify your Tirezapitide provider as soon as possible so your treatment plan can be updated.